RU2020142275A - Method of combined treatment of ingrown nail - Google Patents

Method of combined treatment of ingrown nail Download PDF

Info

Publication number
RU2020142275A
RU2020142275A RU2020142275A RU2020142275A RU2020142275A RU 2020142275 A RU2020142275 A RU 2020142275A RU 2020142275 A RU2020142275 A RU 2020142275A RU 2020142275 A RU2020142275 A RU 2020142275A RU 2020142275 A RU2020142275 A RU 2020142275A
Authority
RU
Russia
Prior art keywords
combined treatment
ingrown nail
nail
ingrown
matrix
Prior art date
Application number
RU2020142275A
Other languages
Russian (ru)
Other versions
RU2794036C2 (en
Inventor
Юлия Дмитриевна Киселева
Original Assignee
Юлия Дмитриевна Киселева
Filing date
Publication date
Application filed by Юлия Дмитриевна Киселева filed Critical Юлия Дмитриевна Киселева
Publication of RU2020142275A publication Critical patent/RU2020142275A/en
Application granted granted Critical
Publication of RU2794036C2 publication Critical patent/RU2794036C2/en

Links

Claims (1)

Способ комбинированного лечения вросшего ногтя, включающий экономную резекцию края ногтевой пластины шириной 5 мм, удаление герминативного матрикса ложкой Фолькмана, отличающийся тем, что ложе матрикса дважды по 3 минуты подвергается воздействию прижигающим препаратом «Веррукацид» в объеме 1 мл.A method for combined treatment of an ingrown nail, including an economical resection of the edge of the nail plate 5 mm wide, removal of the germinal matrix with a Volkmann spoon, characterized in that the matrix bed is exposed to the cauterizing drug "Verrukacid" twice for 3 minutes in a volume of 1 ml.
RU2020142275A 2020-12-21 Method of combined treatment of ingrown nail RU2794036C2 (en)

Publications (2)

Publication Number Publication Date
RU2020142275A true RU2020142275A (en) 2022-06-21
RU2794036C2 RU2794036C2 (en) 2023-04-11

Family

ID=

Similar Documents

Publication Publication Date Title
RU2008127882A (en) TREATMENT OF THE ESOPHAGUS OF BARRETT
ATE405564T1 (en) 1H-IMIDAZOÄ4,5-CUCHINOLIN DERIVATIVES FOR THE TREATMENT OF PROTEIN KINASE-DEPENDENT DISEASES
TW200500067A (en) Salts of codrugs and uses related thereto
HRP20120144T1 (en) Therapeutic uses of compounds having combined sert, 5-ht3 and 5-ht1a activity
RU2009118942A (en) METHOD FOR STIMULATING TISSUE REGENERATION
ECSP078014A (en) DOSAGE REGIME FOR PRASUGREL
ECSP077843A (en) PRURITE TREATMENT OR PREVENTION
AR052152A1 (en) PHARMACEUTICAL PRODUCT FOR THE PREVENTIVE AND THERAPEUTIC TREATMENT OF SUENO DISORDERS
SE0300098D0 (en) Use of cyclin D1 inhibitors
ATE526023T1 (en) PYRIDOXAMINE FOR USE IN THE TREATMENT OF DIABETIC NEPHROPATHY IN TYPE II DIABETES
ATE491451T1 (en) N-(5-ADAMANTANE-1-YL-METHOXY-PENTYL)DESOXYNOJIRIMYCIN OR A PHARMACEUTICAL SALT THEREOF FOR USE IN THE TREATMENT OF INSULIN RESISTANCE
WO2009003694A3 (en) Method for treating diseases related to mitochondrial dysfunction
RU2020142275A (en) Method of combined treatment of ingrown nail
DE602004030048D1 (en) EFFICIENCY
ATE298240T1 (en) SEPARATE DOSE THERAPIES WITH VASCULAR DAMAGED ACTIVITY
MX2009005503A (en) Use of l-carnitine for the preparation of a medicament in the form of eye-drops for treating corneal diseases.
Martini et al. Effects of treatment with maraviroc-a CCR5 inhibitor on human hepatic stellate cells
DE60112750D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING FAMOTIDINE FOR THE TREATMENT OF DEPRESSIONS
RU2002109173A (en) A method for the treatment of degenerative diseases of the retina
EA201991811A1 (en) PHARMACEUTICAL COMPOSITION, DOSAGE AND METHOD OF TREATMENT Ph + LEUKEMIA
UA120764U (en) THE MEDICINAL PRODUCT OF ANCHESTING AND SPASMOLITIC ACTION "FENTANIL"
RU2002115487A (en) METHOD FOR TREATING A RETRIDGING CYLIOCHORIOIDAL EXTRACTION AFTER ANTIGLAUCOMATOUS OPERATION
TH85775A (en) Methods for Inducing Cancer Cell Death and Tumor Degeneration
RU2010143898A (en) ANTITUMOR AGENT, INCLUDING THE CITYIDINE DERIVATIVE AND CARBOPLATIN
RU2002101630A (en) A method of treating endometritis in cows